ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Study Opens For Women At Risk of Ovarian Cancer

October 29, 2004

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

NCI “Rescues” 31 Grants From Other Institutes, Funds Them at 41.6 Million; Scores Were 148-270

August 9, 1974

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013

NCI Starts $2 Million Study On Cancer Patient Job Discrimination

January 17, 1975